Abstract
Breast cancer is one of the most common malignant diagnostic tumors among women and is considered as the second leading cause of mortality in them. Numerous approaches could be recruited for breast cancer management such as surgery, radiation therapy, endocrine, and chemotherapy. In past years, oncologists have prescribed intravenous anticancer drugs for many patients, but nowadays the issue of treatment has changed with the increasing use of oral anticancer drugs. Previous studies have shown that most patients prefer to take oral anticancer drugs and their main reason for this choice is the accessibility of home-based treatment. The objective of this issue was to evaluate the effects of oral therapy regimens such as palbociclib (Ibrance) in combination with aromatase inhibitors in patients with metastatic breast cancer. Our new remedies in the oral therapy field in 2 patients lead to control the progress of malignancy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
